Chun Li
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 1%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
-
- Cancer-related molecular mechanisms research 16
-
- Machine Learning in Bioinformatics 28
- Fractal and DNA sequence analysis 25
- RNA and protein synthesis mechanisms 17
- Epigenetics and DNA Methylation 17
- Co-authors
- Gwo‐Hshiung TzengCheng-Hsin ChiangGerd P. PfeiferReinhard DammannSteven BatesJung‐Hoon YoonPhilip L. ChinMingyao Li
- Journals
- Journal of Vascular Surgery (20 papers)Frontiers in Pharmacology (9 papers)China CDC Weekly (6 papers)Bioinformatics (6 papers)Combinatorial Chemistry & High Throughput Screening (6 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Chun Li
435 papers receiving 12.4k citations
Hit Papers
Peers
Comparison fields: 5 of 215
- Cancer Research 1.5k
- Molecular Biology 4.9k
- Genetics 1.8k
- Pharmacology 530
- Endocrinology, Diabetes and Metabolism 716
Countries citing papers authored by Chun Li
This map shows the geographic impact of Chun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun Li more than expected).
Fields of papers citing papers by Chun Li
This network shows the impact of papers produced by Chun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun Li. The network helps show where Chun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 0 | |
| 11 | 2022 | 13 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2020 | 27 | |
| 16 | 2020 | 30 | |
| 17 | 2013 | 4 | |
| 18 | 2012 | 45 | |
| 19 | Paclitaxel and water-soluble poly (L-glutamic acid)-paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line. | 1998 | 25 |
| 20 | 1992 | 17 |
About Chun Li
Chun Li is a scholar working on Cancer Research, Molecular Biology, Neurology, Genetics and Statistics and Probability, having authored 461 papers that have together received 12.8k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (33 papers), Machine Learning in Bioinformatics (28 papers), Fractal and DNA sequence analysis (25 papers), Aortic aneurysm repair treatments (19 papers), Cardiac, Anesthesia and Surgical Outcomes (17 papers), RNA and protein synthesis mechanisms (17 papers), Epigenetics and DNA Methylation (17 papers) and Cancer-related molecular mechanisms research (16 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (4.9k citations), Genetics (1.8k citations), Pharmacology (530 citations) and Endocrinology, Diabetes and Metabolism (716 citations). Chun Li has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Gwo‐Hshiung Tzeng, Cheng-Hsin Chiang, Gerd P. Pfeifer, Reinhard Dammann, Steven Bates, Jung‐Hoon Yoon, Philip L. Chin, Mingyao Li, Bryan E. Shepherd and Qiuyin Cai. Their work appears in journals such as Journal of Vascular Surgery, Frontiers in Pharmacology, China CDC Weekly, Bioinformatics and Combinatorial Chemistry & High Throughput Screening.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.